Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 136Head and Neck Neoplasms 96Squamous Cell Carcinoma of Head and Neck 89Carcinoma, Non-Small-Cell Lung 58Colonic Neoplasms 44Rectal Neoplasms 38Neoplasm Metastasis 34Neoplasms 28Pancreatic Neoplasms 24Lung Neoplasms 18Carcinoma, Squamous Cell 18Stomach Neoplasms 15Tongue Neoplasms 13Esophageal Neoplasms 13Salivary Gland Neoplasms 11Recurrence 10Breast Neoplasms 10Laryngeal Neoplasms 9Mouth Neoplasms 8Esophageal Squamous Cell Carcinoma 8Carcinoma 8Adenocarcinoma Of Esophagus 8Adenocarcinoma of Lung 7Neoplasms, Squamous Cell 6Hypopharyngeal Neoplasms 6Carcinoma, Renal Cell 6Parkinson Disease 4, Autosomal Dominant Lewy Body 5Oropharyngeal Neoplasms 5Nasopharyngeal Carcinoma 5Carcinoma, Hepatocellular 5

Interventions

Gemcitabine 39Cisplatin 24Oxaliplatin 15pembrolizumab 12Capecitabine 12Fluorouracil 9Leucovorin 7Albumin-Bound Paclitaxel 7lenvatinib 6Radiofrequency Ablation 6Panitumumab 6130-nm albumin-bound paclitaxel 6Irinotecan 5Bevacizumab 5durvalumab 4Taxes 4Nivolumab 4Hepatectomy 4Drug Therapy 4tremelimumab 3apatinib 3Radiosurgery 3Platinum 3Injections 3Floxuridine 3Cetuximab 31,2-diaminocyclohexaneplatinum II citrate 3trametinib 2spartalizumab 2sintilimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Cholangiocarcinoma × Cetuximab × Clear all
NCT03693807 2026-02-06

A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
35 enrolled 14 charts
Gastrointestinal

Colorectal Neoplasms, Cholangiocarcinoma

NCT01247337 2020-10-05

Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma

Herlev Hospital

Phase 2 Completed
56 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT01267344 2016-05-04

BTC

National Health Research Institutes, Taiwan

Phase 2 Completed
122 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡